AAAAAA

   
Results: 1-10 |
Results: 10
ISSUES FACING THE NEW FDA COMMISSIONER
Authors: LASAGNA L KAITIN KI
Citation: L. Lasagna et Ki. Kaitin, ISSUES FACING THE NEW FDA COMMISSIONER, Science, 282(5392), 1998, pp. 1263-1263
USER FEES AND THE NEW DRUG APPROVAL PROCESS
Authors: KAITIN KI POWERS P
Citation: Ki. Kaitin et P. Powers, USER FEES AND THE NEW DRUG APPROVAL PROCESS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 2-2
THE PRESCRIPTION DRUG-USER FEE ACT OF 1992 - A 5-YEAR EXPERIMENT FOR INDUSTRY AND THE FDA
Authors: SHULMAN SR KAITIN KI
Citation: Sr. Shulman et Ki. Kaitin, THE PRESCRIPTION DRUG-USER FEE ACT OF 1992 - A 5-YEAR EXPERIMENT FOR INDUSTRY AND THE FDA, PharmacoEconomics, 9(2), 1996, pp. 121-133
US APPROVED BIOLOGICS - 1980-1994
Authors: GOSSE ME MANOCCHIA M KAITIN KI
Citation: Me. Gosse et al., US APPROVED BIOLOGICS - 1980-1994, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 15-15
THE NEW DRUG APPROVALS OF 1993, 1994, AND 1995 - TRENDS IN DRUG DEVELOPMENT
Authors: KAITIN KI MANOCCHIA M LASAGNA L
Citation: Ki. Kaitin et al., THE NEW DRUG APPROVALS OF 1993, 1994, AND 1995 - TRENDS IN DRUG DEVELOPMENT, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 16-16
DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE
Authors: BAKKE OM MANOCCHIA M DEABAJO F KAITIN KI LASAGNA L
Citation: Om. Bakke et al., DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE, Clinical pharmacology and therapeutics, 58(1), 1995, pp. 108-117
DRUG SAFETY DISCONTINUATIONS - A COMPARISON OF UK, US, AND SPAIN 1974-93
Authors: BAKKE OM MANOCCHIA M DEABAJO F KAITIN KI LASAGNA L
Citation: Om. Bakke et al., DRUG SAFETY DISCONTINUATIONS - A COMPARISON OF UK, US, AND SPAIN 1974-93, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 195-195
BAD MEDICINE - THE PRESCRIPTION DRUG-INDUSTRY IN THE THIRD-WORLD - SILVERMAN,M, LYDECKER,M, LEE,PR
Authors: KAITIN KI
Citation: Ki. Kaitin, BAD MEDICINE - THE PRESCRIPTION DRUG-INDUSTRY IN THE THIRD-WORLD - SILVERMAN,M, LYDECKER,M, LEE,PR, Journal of health politics, policy and law, 19(4), 1994, pp. 922-925
THE NEW DRUG APPROVALS OF 1990, 1991, AND 1992 - TRENDS IN DRUG DEVELOPMENT
Authors: KAITIN KI MANOCCHIA M SEIBRING M LASAGNA L
Citation: Ki. Kaitin et al., THE NEW DRUG APPROVALS OF 1990, 1991, AND 1992 - TRENDS IN DRUG DEVELOPMENT, Journal of clinical pharmacology, 34(2), 1994, pp. 120-127
THE ROLE OF THE RESEARCH-BASED PHARMACEUTICAL-INDUSTRY IN MEDICAL PROGRESS IN THE UNITED-STATES
Authors: KAITIN KI BRYANT NR LASAGNA L
Citation: Ki. Kaitin et al., THE ROLE OF THE RESEARCH-BASED PHARMACEUTICAL-INDUSTRY IN MEDICAL PROGRESS IN THE UNITED-STATES, Journal of clinical pharmacology, 33(5), 1993, pp. 412-417
Risultati: 1-10 |